A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

Clinical trial NCT05293496 · COMPLETED

Trial details

NCT number: NCT05293496
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Castration-Resistant Prostatic Cancer Malignant Melanoma Pancreatic Ductal Carcinoma Hepatocellular Cancer Epithelial Ovarian Cancer Renal Cell Carcinoma

Start date: 2022-04-19
Primary completion: 2025-06-24
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.